πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 180 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8735075

Cancer screening by detection of ultrastructural and molecular markers

Northwestern University Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8691963

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact min

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8669101

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid f

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8647818

Molecular scaffolds for HIV-1 immunogens

The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health Β· Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8632771

High molecular weight derivatives of vitamin K-dependent polypeptides

The United States of America as represented by Department of Veterens Affairs Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8591862

Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mamm

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8552067

Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein i

The Regents of the University of California Β· Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8545813

Pre-templated macromolecular architectures with multiple Gd(III) complexes and methods of

Northwestern University Β· Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481478

Method for automated, large-scale measurement of the molecular flux rates of the proteome

The Regents of the University of California Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8449877

Pharmaceutically purified intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8288530

Method of preparing macromolecular contrast agents and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8263657

Inhibitors against the production and release of inflammatory cytokines

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8148343

Tumor suppressor factor

Molecular Discover Systems Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129335

Method for automated, large-scale measurement of the molecular flux rates of the proteome

The Regents of the University of California Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097610

Derivative having PPAR agonistic activity

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097759

Inflammatory cytokine release inhibitor

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8076100

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044236

Carboxilic acid derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003091

Pharmaceutical compositions comprising purified intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998992

Oxazolidinone derivative having inhibitory activity on 11Ξ²-hydroxysteroid dehydrogenase ty

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884234

N-phenyloxamide derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7700655

Antiallergic agents

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7671058

N-(3,4-disubstituted phenyl) salicylamide derivatives

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7662999

Recognition of oligosaccharide molecular targets by polycationic small molecule inhibitors

The United States of America as represented by the Department of Health and Human Services (DHHS) Β· Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted